Lv31
326 积分 2024-08-27 加入
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
1小时前
已完结
Once-weekly IcoSema versus multiple daily insulin injections in type 2 diabetes management (COMBINE 3): an open-label, multicentre, treat-to-target, non-inferiority, randomised, phase 3a trial
21天前
已完结
Once‑weekly IcoSema versus once‑weekly insulin icodec in type 2 diabetes management (COMBINE 1): an open‑label, multicentre, treat‑to‑target, randomised, phase 3a trial
21天前
已完结
德谷胰岛素利拉鲁肽注射液临床应用专家指导建议
1个月前
已完结
A Phase 1 Study to Assess the Effect of Supratherapeutic Doses of Iptacopan on Cardiac Conduction Parameters and Safety
1个月前
已关闭
A First-in-Human, Phase 1 Study to Assess the Pharmacodynamic Properties of Single-Dose Iptacopan (CLNP023X2101)
1个月前
已完结
Effi cacy and safety of a fi xed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes
1个月前
已完结
国家基层肥胖症综合管理技术指南（2025）
2个月前
已完结
肠肠促胰素类减重药物临床应用专家共识（2025版）
2个月前
已完结
体重管理门诊建设专家指导意见（2025版）
2个月前
已完结
皖公网安备34019202002308
